Mechanism of action of coumarin and silver(I)-coumarin complexes against the pathogenic yeast Candida albicans

被引:104
作者
Thati, Bhumika
Noble, Andy
Rowan, Raymond
Creaven, Bernadette S.
Walsh, Maureen
McCann, Malachy
Egan, Denise
Kavanagh, Kevin [1 ]
机构
[1] Natl Univ Ireland, Natl Ins Cellular Biotechnol, Dept Biol, Med Mycol Unit, Maynooth, Kildare, Ireland
[2] Inst Technol Tallaght, Pharma R&D Team, Dublin 24, Ireland
[3] Natl Univ Ireland, Dept Chem, Maynooth, Kildare, Ireland
关键词
anti-fungal; Candida albicans; coumarin; phenanthroline; silver(I); yeast;
D O I
10.1016/j.tiv.2007.01.022
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The anti-fungal activity and mode of action of a range of silver(I)-coumarin complexes was examined. The most potent silver(I)-coumarin complexes, namely 7-hydroxycoumarin-3-carboxylatosilver(I), 6-hydroxycoumarin-3-carboxylatosilver(I) and 4-oxy-3-nitrocoumarinbis(1,10-phenanthroline)silver(I), had MICSO values of between 69.1 and 4.6 pM against the pathogenic yeast Candida albicans. These compounds also reduced respiration, lowered the ergosterol content of cells and increased the trans-membrane leakage of amino acids. A number of the complexes disrupted cytochrome synthesis in the cell and induced the appearance of morphological features consistent with cell death by apoptosis. These compounds appear to act by disrupting the synthesis of cytochromes which directly affects the cell's ability to respire. A reduction in respiration leads to a depletion in ergosterol biosynthesis and a consequent disruption of the integrity of the cell membrane. Disruption of cytochrome biosynthesis may induce the onset of apoptosis which has been shown previously to be triggered by alteration in the location of cytochrome c. Silver(I)-cournarin complexes demonstrate good anti-fungal activity and manifest a mode of action distinct to that of the conventional azole and polyene drugs thus raising the possibility of their use when resistance to conventional drug has emerged or in combination with such drugs. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:801 / 808
页数:8
相关论文
共 30 条
[11]   Activation of mitogen activated protein kinase pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycomarin in human malignant melanoma cells [J].
Finn, GJ ;
Creaven, BS ;
Egan, DA .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 26 (01) :16-25
[12]   Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase [J].
Finn, GJ ;
Creaven, BS ;
Egan, DA .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (09) :1779-1788
[13]   In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines [J].
Finn, GJ ;
Kenealy, E ;
Creaven, BS ;
Egan, DA .
CANCER LETTERS, 2002, 183 (01) :61-68
[14]   Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B [J].
Geraghty, P ;
Kavanagh, K .
ARCHIVES OF MICROBIOLOGY, 2003, 179 (04) :295-300
[15]   The central executioners of apoptosis: caspases or mitochondria? [J].
Green, D ;
Kroemer, G .
TRENDS IN CELL BIOLOGY, 1998, 8 (07) :267-271
[16]  
IRENA K, 2001, EUR J MED CHEM, V36, P339
[17]   Antimicrobial activity of trifluoromethyl ketones and their synergism with promethazine [J].
Kawase, M ;
Motohashi, N ;
Sakagami, H ;
Kanamoto, T ;
Nakashima, H ;
Ferenczy, L ;
Wolfard, K ;
Miskolci, C ;
Molnár, J .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (02) :161-165
[18]   Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Delta(5,6)-desaturation [J].
Kelly, SL ;
Lamb, DC ;
Kelly, DE ;
Manning, NJ ;
Loeffler, J ;
Hebart, H ;
Schumacher, U ;
Einsele, H .
FEBS LETTERS, 1997, 400 (01) :80-82
[19]   Antifungal drug resistance of pathogenic fungi [J].
Kontoyiannis, DP ;
Lewis, RE .
LANCET, 2002, 359 (9312) :1135-1144
[20]   Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B [J].
Laurin, P ;
Ferroud, D ;
Klich, M ;
Dupuis-Hamelin, C ;
Mauvais, P ;
Lassaigne, P ;
Bonnefoy, A ;
Musicki, B .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) :2079-2084